Company: AMWL
Filing Date: 2025-02-12
Form Type: 10-K
Source: 0000950170-25-019024
Chunk: 190

Company: American Well Corp
Filing Date: 2025-02-12
Form: 10-K
Item: Item 1B
Chunk 190
---
722
    )

    (166,508
    )

    (207,870
    )

    Cash, cash equivalents, and restricted cash at beginning of period

    372,833

    539,341

    747,211

    Cash, cash equivalents, and restricted cash at end of period
     
    $
    229,111

    $
    372,833

    $
    539,341

    Cash, cash equivalents, and restricted cash at end of period:

    Cash and cash equivalents

    228,316

    372,038

    538,546

    Restricted cash

    795

    795

    795

    Total cash, cash equivalents, and restricted cash at end of period
     
    $
    229,111

    $
    372,833

    $
    539,341

    Supplemental disclosure of cash flow information:

    Cash paid for income taxes
     
    $
    4,105

    $
    5,003

    $
    1,723

    Supplemental disclosure of non-cash investing and financing   activities:

    Issuance of common stock in settlement of earnout
     
    $
    —

    $
    —

    $
    17,243

The accompanying notes are an integral part of these consolidated financial statements. 

F-7

AMERICAN WELL CORPORATION 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 

(In thousands, except share and per share amounts) 

1. Organization and Description of Business Description of Business American Well Corporation (the “Company”) was incorporated under the laws of the State of Delaware in June 2006. The Company is headquartered in Boston, Massachusetts. The Company is a leading enterprise platform and software company that enables the digital distribution and delivery of care for healthcare’s key stakeholders. The Company’s scalable technology is deployed at the enterprise level of clients, embeds into existing offerings and workflows, spans the continuum of care and enables the delivery of this care across a wide variety of clinical, retail, school and home settings. Reverse Stock SplitOn June 18, 2024, the Company’s stockholders approved a reverse stock split of its Class A common stock, Class B common stock and Class C common stock (collectively, the "common stock") at a ratio ranging from 1-for-10 to 1-for-20, with the exact ratio determined by the Company’s Board of